Novel drug shows early promise in treating multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-of

Updated on: January 15,2024

Novel drug shows early promise in treating multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-of

Updated on:January 15,2024

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Updated on: June 06,2024

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Updated on:June 06,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on: February 24,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on:February 24,2024

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on: February 03,2024

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on:February 03,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on: January 30,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on:January 30,2024

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Updated on: May 25,2024

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Updated on:May 25,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on: January 30,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on:January 30,2024

Computational tool reveals untapped efficacy of cancer drug, leveling up cancer fight

byPurdue UniversityBenchmark for evaluating and optimizing existing pathway analysis methods. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51859-9Research from Purdue

Updated on: September 28,2024

Computational tool reveals untapped efficacy of cancer drug, leveling up cancer fight

byPurdue UniversityBenchmark for evaluating and optimizing existing pathway analysis methods. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51859-9Research from Purdue

Updated on:September 28,2024

Mediterranean diet linked to lower risk of mortality, especially from cardiovascular disease, in cancer survivors

by Istituto Neurologico Mediterraneo Neuromed I.R.C.C.S.Credit: Unsplash/CC0 Public DomainThe Mediterranean diet is a powerful ally for health even after a cancer diagnosis. This is the key result of

Updated on: July 05,2024

Mediterranean diet linked to lower risk of mortality, especially from cardiovascular disease, in cancer survivors

by Istituto Neurologico Mediterraneo Neuromed I.R.C.C.S.Credit: Unsplash/CC0 Public DomainThe Mediterranean diet is a powerful ally for health even after a cancer diagnosis. This is the key result of

Updated on:July 05,2024

Drugs to prevent anxiety, stress reactions and inflammation found to reduce risk of metastases after tumor surgery

by Tel Aviv UniversityStress responses and reciprocal stress–cancer interactions. Credit:European Journal of Surgical Oncology(2022). DOI: 10.1016/j.ejso.2022.10.013A short, simple an

Updated on: February 18,2024

Drugs to prevent anxiety, stress reactions and inflammation found to reduce risk of metastases after tumor surgery

by Tel Aviv UniversityStress responses and reciprocal stress–cancer interactions. Credit:European Journal of Surgical Oncology(2022). DOI: 10.1016/j.ejso.2022.10.013A short, simple an

Updated on:February 18,2024

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on: April 09,2024

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on:April 09,2024

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on: April 01,2024

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on:April 01,2024